In case the tumor defense relies on the activation of CD40+ host cells such as antigen-presenting cells by CD40L-expressing T cells, the tumor growth rates should be comparable in CD40 or CD40L knockout (KO) mouse strains. The gene discussed is CD40; the disease is neoplasm.